Tiny Biotech Just Beat AbbVie's Drug: Risk for Investors?
A tiny biotech just beat AbbVie's blockbuster in early-stage results, prompting fresh questions about the durability ...
Identify compelling low-cost index funds for retirement by evaluating tracking error, fees, and diversification. Build a lineup aligned with long-term goals.
27,243 articlesA tiny biotech just beat AbbVie's blockbuster in early-stage results, prompting fresh questions about the durability ...
What if a philanthropic powerhouse holds a large share of its stock in just a few mega-cap names? This article explor...
Investors watched Ford stock sink this week as the company faced a mix of softer sales signals, strategic bets on ene...
In this in-depth piece, we explore Mamoon Hamid’s approach to AI investing at Kleiner Perkins, the lessons from early...
Goldman Sachs and JPMorgan cut targets on Kohl’s as consumer demand cools, signaling a tougher 2026. The moves come a...
Oil tensions in the Persian Gulf push crude prices higher while automakers reassess EV investments. Investors are ask...
U.S. drone output is under scrutiny as manufacturers push for scale. Red Cat and AeroVironment highlight a market shi...
Snap faces another disappointing quarter as ad revenue slows and user growth stalls. With mounting headwinds, many an...
Ford kicked off the year with strong truck demand and a raised outlook. Now the automaker aims to sustain momentum in...
New data from the New York Fed show a sharp rise in household pessimism as rent and food costs rise, threatening cons...
A Goldman Sachs strategist says the AI boom is turning into a market become ‘rubber band’ moment, as cheap software d...
Apple raises hardware prices by up to 20% amid memory-cost pressures, while Amazon’s AWS sees robust cloud demand. Th...